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The management of patients with severe brain injuries and prolonged disorders of consciousness 
(DOC) raises important issues particularly with respect to their therapeutic options. The lack of 
treatment is challenged by new clinical and neuroimaging data indicating that some patients with 
prolonged DOC may benefit from therapeutic interventions, even years after the injury. The 
majority of the studies aiming at improving patients’ level of consciousness and functional 
recovery includes behavioural and brain imaging open-label trials and case-reports, but several 
randomized clinical trials (RCT) have been conducted, especially using non-invasive brain 
stimulation. Only a couple of RCTs focused on the effects of drugs or sensory stimulation 
approaches, and only two Class II studies, on amantadine and transcranial direct current 
stimulation, have been published. While new therapeutic approaches seem to be valuable for 
patients with prolonged DOC, optimized stimulation parameters, alternative drugs or 
rehabilitation strategies still need to be tested and validated.  
 
List of abbreviations:  
CMD: Cognitive motor dissociation 
CS: Confusional State 
CRS-R: Coma recovery scale-revised 
DBS: Deep brain stimulation 
DLPFC: Dorsolateral prefrontal cortex 
DOC: Disorders of consciousness 
EEG: Electroencephalography 
EMCS: Emergence from the minimally conscious state 
IBP: Intrathecal baclofen pomp  
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LIFUP: Low intensity focused ultrasound pulse  
LIS: Locked-in syndrome 
MCS: Minimally conscious state 
MRI: Magnetic resonance imaging 
PET: Positron emission tomography  
TBI: Traumatic brain injury 
tDCS: Transcranial direct current stimulation 
tRNS: Transcranial random noise stimulation 
RCT: Randomized clinical trials 
rTMS: Repetitive transcranial magnetic stimulation 
VNS: Vagal nerve stimulation 





A lot of work has been accomplished to correctly diagnose patients with disorders of 
consciousness (DOC)1,2 to establish prognostic indicators3 and to understand the neural 
correlates of consciousness,4 which is crucial since misdiagnosis can lead to important medical 
decisions such as premature withdrawal of life-sustaining care.5,6 DOC includes the unresponsive 
wakefulness syndrome/vegetative state (UWS/VS; reflex behaviors only) and the minimally 
conscious state (MCS; clinical demonstration of signs of consciousness).5,7 Once patients recover 
functional communication or object use, they emerge from the MCS (EMCS). Recently, 
additional entities have been proposed when there is a dissociation between clinical diagnosis 
and neuroimaging results showing atypical brain activation: MCS* and cognitive motor 
dissociation (CMD; see glossary panel).8,9 These patients who recovered from coma can remain 
severely disabled for several months, years or even decades.  
Regarding therapeutic options, only a limited number of studies have investigated how to treat 
these patients. In the past few years, the field of treatment for patients with DOC has however 
evolved rapidly but patients’ clinical management remains challenging, mostly because these 
patients cannot communicate and are dependent on others for all cares. On the one hand, there is 
a risk of despair of the medical community that should be avoided, but on the other hand, there is 
also a risk of giving false hope to families that needs to be taken into account. 
The American practice guidelines for DOC patients10 published in 2018 only recommends 
amantadine for patients with UWS and MCS between 4 and 16 weeks after a traumatic brain 
injury (TBI) based on one randomized clinical trial (RCT)11. Given that these recommendations 
were developed based on explicit rules for establishing guidelines, many studies failed to meet 
their inclusion criteria. In this review, we provide a more extensive state of the art of available 
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therapeutic options for patients with prolonged DOC (i.e., more than 28 days). We discuss  
pharmacological and non-pharmacological interventions with the strongest evidence and for 
which robust RCTs have been published. If no RCTs were available, we present open-label 
studies and anecdotal case-reports with careful interpretation, as they may still give insightful 
results to guide future research. We also report neuroimaging and neurophysiological results 
associated with positive treatment responses.  
 
Pharmacological treatments  
Amantadine (dopamine agonist and NMDA antagonist11–14), intrathecal baclofen (GABA 
agonist15), zolpidem (nonbenzodiazepine GABA agonist16,17), midazolam (benzodiazepine 
GABA agonist18) and ziconotine (calcium channel blocker19) have been employed to improve the 
level of consciousness and functional recovery in patients with DOC.  
Amantadine and other neurostimulants 
Only one large sample class II RCT on amantadine was conducted in 184 TBI patients with 
prolonged DOC (28-112 days post-injury) who received either amantadine (up to twice 
200mg/day) or placebo for 4 weeks, and were followed for two extra weeks11. The amantadine 
group recovered faster than the placebo group during the course of the treatment as measured by 
the Disability Rating Scale.20  
In non-TBI, one uncontrolled case-report has described the positive behavioural effects of 
amantadine in a MCS patient (16 months post-injury).21 An older controlled case-report showed 
an increased metabolism in the fronto-parietal cortex during amantadine in an anoxic MCS 
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responder (figure 2A).12 These two case-reports should encourage the development of RCT 
evaluating the effect of amantadine in other etiologies than TBI.  
Beside amantadine, the administration of one or more neurostimulants (i.e., amantadine, 
bromocriptine, levodopa, methylphenidate, and modafinil) has also been explored in a 
retrospective study in a cohort of 115 patients with DOC (< 180 days post-onset).13 The number 
of neurostimulants did not induced meaningful behavioral improvement in this observational 
study. 
Zolpidem 
This hypnotic agent is known to induce paradoxical transient effects in rare cases. A double-
blind crossover RCT in 84 patients in UWS and MCS (> 4 months post-injury) identified 4 
responders (5%) following the intake of 10 mg of zolpidem. These 4 patients gained at least 5 
points on the Coma Recovery Scale-Revised (CRS-R1); one UWS and one MCS- became MCS+ 
and two MCS+ emerged (i.e., EMCS) for around two hours.22 Another RCT performed on 8 
patients in UWS (1-114 months post-injury) only noticed slight clinical changes (i.e., yawns and 
hiccups – but no changes on the CRS-R) combined with an activation of electroencephalographic 
(EEG) activity (i.e., faster frequency and lower amplitude).23 An additional two-phase study (i.e., 
open-label and then a placebo-controlled trial if there was a change of CRS-R diagnosis) 
included 60 patients in UWS and MCS patients (1 month to 24 years post-onset).16 Twelve 
patients (20%) showed behavioral improvements (e.g., command following, object localization) 
without a change of diagnosis. One patient could functionally use some objects after the open 
trial, but did not demonstrate any improvement in the placebo-controlled phase. In a last case-
report, recovery of consciousness was observed in a patient in UWS (> 3 years post-cardiac 
arrest) when using higher dosage of zolpidem (30 mg instead of 10 mg).24 The patient started to 
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demonstrate signs of consciousness when receiving 20 mg and further improved after 30 mg of 
zolpidem, suggesting that higher dosage may induce stronger effects. 
Regarding zolpidem’s brain responses, studies using EEG17, functional magnetic resonance 
imaging (fMRI)25 and positron emission tomography (PET)26 have identified an increase in brain 
activity, mainly in prefrontal regions (figure 2B), which supports the mesocircuit hypothesis 
(figure 3). This model explains how zolpidem can modulate the thalamo-cortical connectivity 
through the disinhibition of the thalamus by acting on the globus pallidus interna and, 
consequently, promotes the recovery of consciousness.27  
To date, zolpidem demonstrates improvement of consciousness and functional recovery (even if 
transient) in around 5% of patients. It is crucial to next determine the behavioral and 
physiological profile of zolpidem responders to better identify which patients could benefit from 
this treatment.  
Intrathecal baclofen and other drugs 
Intrathecal baclofen is primarily used as a centrally acting treatment for spasticity but it has been 
suggested as a potential drug to stimulate the recovery of consciousness in a few uncontrolled 
studies and case-reports.15,28 The effects of midazolam (benzodiazepine receptor agonist)18 and 
ziconitide (atypical analgesic, selective blocker of N-type calcium channels)19 have also been 
reported in two single-case studies as stimulant for the recovery of consciousness of patients with 
prolonged DOC (one MCS and one UWS, respectively).18,19 These anecdotal findings need to be 





Non-pharmacological interventions have also been attempted to improve consciousness and 
functional recovery in patients with DOC. These include non-invasive brain stimulations 
(transcranial direct current stimulation – tDCS, repeated transcranial magnetic stimulation – 
rTMS, transcutaneous auricular vagal nerve stimulation – taVNS, low intensity focused 
ultrasound pulse – LIFUP), invasive brain stimulation (DBS, invasive VNS), and sensory 
stimulation programs. 
Non-invasive brain stimulations 
 Transcranial direct current stimulation  
A first double-blind RCT tested the effect of prefrontal tDCS (i.e., anode over the left 
dorsolateral prefrontal cortex – DLPFC - for 20 minutes at 2mA) on 55 patients, both in acute 
and prolonged DOC (1 week to 26 years post-injury).29 At the group level, behavioral 
improvements (as measured by the CRS-R) were observed for MCS patients, but not for UWS 
patients. At the individual level, 13/30 MCS (43%) showed a tDCS-related improvement (i.e., 
recovery of a clinical sign of consciousness never observed before tDCS, neither during sham 
session). Importantly, no tDCS related side-effects were reported in any patients. In a case-
report, one patient considered in UWS showed a response to command after one session of 
DLPFC tDCS.30 When looking at the neuroimaging assessments, a preservation of brain activity 
closer to what is usually observed in MCS+ patients was identified. In another RCT, tDCS was 
applied once a day for 5 consecutive days in 16 patients in MCS (5 months to 30 years post-
injury) and the effects were assessed daily and at one-week follow-up.31 A clinical improvement 
(e.g., recovery of command following, visual pursuit, object localization or manipulation) was 
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observed after 5 days of tDCS and the effects remained up to a week.31 Some patients did not 
respond directly after the first stimulation indicating that a single session of tDCS is insufficient 
to determine if a patient can benefit from the technique or not. A non-randomized controlled 
study evaluated the clinical effects of sham then active tDCS applied either over the DLPFC or 
the primary sensorimotor cortex for 5 days in UWS or MCS (6 months to 10 years post-injury).32 
The 3 MCS improved regardless of the site of stimulation (1 MCS received prefrontal tDCS and 
2 sensorimotor tDCS), while none of the 7 patients in UWS responded. Another double-blind 
RCT showed that the observed behavioral improvement (CRS-R total score) in 5/13 patients 
following 5 sessions of tDCS were paralleled with EEG changes (enhancement of EEG 
background).33 One more double-blind RCT included 26 patients with DOC (1-17 months post-
onset) who received 20 sessions of active or sham prefrontal tDCS over 10 days.34 Clinical 
improvement was observed in the MCS group but not in the UWS group, combined with an 
increase in P300 amplitude for the responders. Finally, another RCT in 27 patients in MCS (10 
months to 33 years post-injury) evaluated the effects of 20 sessions within 4 weeks of DLPFC 
tDCS applied by the patients’ relatives or caregivers at home or in nursing homes.35 While the 
overall compliance was good (i.e., 96% of sessions completed), the behavioral effect was not 
significant. However, when excluding the 5 patients who did not receive at least 80% of the 
tDCS sessions, a significant treatment effect was observed for the remaining 22 patients. Patients 
can thus demonstrate tDCS clinical improvements, such as the recovery of objects manipulation 
or functional communication, even years after the brain injury, but a chronic application of the 
proposed tDCS treatment is required. Beside, tDCS, 101-640Hz transcranial random noise 
stimulation was applied over the prefrontal cortex for 5 daily sessions of 20 minutes in a pilot 
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RCT on 9 patients in UWS (30 days to 4 months post-injury) which showed no clinical 
improvement.36  
Regarding neuroimaging data of tDCS responders, a common pattern of metabolic and grey 
matter preservations has been observed in 8 responders compared to 13 non-responders patients 
in MCS.37 Clinical improvement following tDCS seems to require a partial functional and 
structural preservation of the stimulated area (DLPFC) and other critical brain regions involved 
in consciousness recovery such as the precuneus and the thalamus (figure 2C). A higher cortical 
connectivity within the theta band was also observed in responders as compared to non-
responders.38 Additionally, recent EEG studies identified an increase in fronto-parietal coherence 
in the theta band after active DFPLC tDCS in MCS patients and an increased in global cortical 
excitability as measured with TMS-EEG.39,40 
Compared to DLPFC stimulation, tDCS on the precuneus or the orbitofrontal cortex has shown 
less promising results.41,42 In a double-blind RCT, tDCS was applied over the precuneus once a 
day for 20 minutes during 5 days in 33 patients in MCS (1-26 months post-injury).41 An 
improvement at the group level was observed after the tDCS sessions but the effect did not last 
when reassessed 5 days later. At the single subject level, 6/33 patients were identified as 
responders (18%) with the recovery of visual pursuit, command following, automatic motor 
reaction or objects manipulation or localization. In one prospective open-label study, no 
behavioral changes were observed after tDCS applied over the orbitofrontal cortex in 22 patients 
with prolonged DOC (4-33 months post-onset).42 Note that cortical connectivity and excitability 
were increased after tDCS in all MCS and in some UWS patients.  
The prefrontal cortex seems therefore to be a better target for stimulation. DLPFC stimulation 
may induce a stronger connectivity between the prefrontal cortex and the thalamus since the 
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prefrontal cortex has many connections with the striatum. By stimulating the striatum, a 
disinhibition of the thalamus may occur, and this may reinforce thalamo-cortical connectivity 
(figure 3).43,44  
 Repeated transcranial magnetic stimulation 
In a first double-blind RCT on 11 patients with UWS (9-85 months post-injury), no behavioral 
improvements were identified following rTMS sessions at 20Hz applied over M1 for 10 
minutes.45 The second RCT trial reported no behavioral improvement after one session of M1 
20Hz rTMS for ~10 minutes in 10 patients with DOC (1-26 months post-onset) but improved 
hemodynamic functions (i.e., cerebral blood flow velocity) in the MCS as compared to the UWS 
group.46 5-Hz rTMS was applied on M1 for ~7 minutes in a third RCT in 5 UWS and 5 MCS 
patients (5-23 months post-injury) evaluating its effects on sleep-wake cycles.47 Even if there 
was no behavioral effect reported, significant rTMS after-effects regarding the slow wave 
activity power were detected in the MCS but not in the UWS group. The last small sample 
crossover RCT evaluated the effects of 5 sessions of M1 20 Hz rTMS, lasting ~10 minutes, in 3 
UWS, 2 MCS and 1 EMCS patients (1-28 months post-injury).48 At the group level, no treatment 
effect was found, but at the single subject level, one UWS patient recovered localization to 
painful stimulation and maintained this behavior at 1-week follow-up. This clinical improvement 
was paralleled with an increase in alpha and beta power. Additionally, in a case-report, an 
increased absolute and relative power in delta, alpha and beta frequency bands was found with 
improved signs of consciousness in 1 patient in MCS after M1 rTMS49 (figure 2D).  
Besides M1, the DLPFC has also been targeted in a few uncontrolled studies. The effect of 20 
sessions of 10Hz DLPFC rTMS (each session lasting 11 minutes) was evaluated in 16 patients 
with DOC (3-35 months post-injury) in a single-blind uncontrolled study.50 CRS-R total score 
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increased in all 5 patients in MCS and in 4/11 patients with UWS, and the improvements were 
more important in MCS patients. In a small sample open-label study, 10 post-anoxic patients 
with UWS (4-15 months post-onset) received a single session of DLPFC 10-Hz rTMS for 60 
minutes.51 While no clinical effects were observed at the group level, 3 patients demonstrated 
behavioral improvements (i.e., recovery of pain localization for all 3 patients) associated with an 
increase in brain connectivity (as measured with dual-coil TMS). Finally, the safety of repeated 
DLPFC rTMS was reported in two patients with DOC,  months and 9 years post-onset, who 
received 30 sessions of rTMS and who showed no serious adverse-event related to rTMS.52 The 
absence of severe adverse-events linked to prolonged use of rTMS is encouraging, but no 
conclusion can be drawn based on these two case-reports only.  
As for tDCS, it may be possible that prefrontal area could be a better target, rather than the motor 
cortex, as all M1 rTMS studies have failed to demonstrate clinical improvements. Preliminary 
results of uncontrolled studies should encourage the design of rTMS RCTs targeting the 
prefrontal region.  
        Other novel approaches 
Novel non-invasive brain stimulation techniques, including LIFUP, taVNS and spinal cord 
stimulation, have been tested in a few case-reports.53–55 The only published report of a patient in 
MCS (19 days post-TBI) who received one session of LIFUP targeting the central thalamus 
(figure 2E) showed a recovery of language comprehension and spatio-temporal orientation a few 
days later.56 The effects of taVNS were presented in another case-report of UWS patient (50 days 
post-anoxia) (figure 2F53). After 4 weeks of treatment (two daily stimulation sessions for 30 
minutes each, with an intensity of 4-6 mA, at a frequency of 20 Hz), the patient regained some 
signs of consciousness. The caloric vestibular stimulation is another technique that has been 
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tested in two patients in MCS (1 hemorrhagic stroke and 1 anoxia, about 6 months post-onset).54 
The protocol included two active and two sham daily sessions during 4 or 5 days per week. Both 
patients demonstrated clinical improvement with the CRS-R (i.e., arousal and auditory scales) 
and the Wessex Head Injury Matrix (i.e., gesture making and selective responses to relatives). 
Spinal cord stimulation has also been explored in some case-reports or uncontrolled studies.55,57 
However, no RCT evaluating their effects have been performed so far, and the majority of the 
available studies did not use standardized scales or well-defined outcomes to assess the effects of 
these interventions. As for all uncontrolled trials, the results of these case-reports could be linked 
to spontaneous recovery; however, these articles can be seen as feasibility studies.  
In sum, regarding the growing field of non-invasive brain stimulation techniques (10 out of the 
14 RCTs reviewed from these last 5 years investigated the effect of non-invasive brain 
stimulation – see table 1), tDCS is the only intervention that has shown a clinical effect in 
multiple RCTs, more specifically in patients in MCS. However, not all patients respond, its 
effects are limited to the recovery of a few signs of consciousness (e.g., recovery of visual 
pursuit, command following, object localization or manipulation) and change of diagnosis are 
transient and only observed in rare cases. It thus needs to be optimized to induce long-lasting 
clinically relevant improvements such as recovery of communication. In addition, others brain 
areas could be stimulated according to patients’ remaining brain structures and function as it has 
been shown that patients’ clinical responsiveness is associated to the relative preservation of grey 
matter, brain metabolism, and cortical connectivity.37,38 The emerging field of current modelling 
could also help the development of patients’ tailored stimulation montages based on individual 
structural brain changes.58 To this aim, neuroimaging should be performed before brain 
stimulation (i.e., tDCS and rTMS) to document the exact area to be stimulated and to tailor 
 14 
patients’ stimulation based on their brain lesions. One important note is the absence of side-
effects observed in all tDCS or rTMS studies assessing side-effects (3 studies did not mention if 
they collected possible adverse-events). 
Regarding the other non-invasive interventions, rTMS did not show significant effect at the 
group level in any RCTs (all class III). Nonetheless, many parameters (e.g., type, frequency or 
duration of stimulation) could be optimized to enhance its efficacy.  
Invasive brain stimulation 
A 7-year well-designed prospective open-label study on the effects of DBS in patients with DOC 
(>6 months post-injury) report that only a very limited number of patients met the inclusion 
criteria (5/40) (e.g., EEG desynchronized activity <5% of the recorded time, somatosensory and 
auditory evoked potentials evoked on at least one side).59 Out of the 5 eligible patients, two did 
not receive surgery due to issue with the legal representative. The 3 patients who could undergo 
the procedure showed limited behavioral improvements (CRS-R total scores improved from 1 to 
3 points) or even worsened behaviorally (decrease in CRS-R compared to baseline). In addition, 
the electrodes had to be removed for 1 patient due to a scalp infection. Given these results, the 
use of DBS to improve patients’ recovery seems limited. In another prospective open-label study 
including 14 patients in UWS and MCS (2 months to 11.5 years post-injury), the positive effects 
of DBS of the thalamic reticular nuclei on clinical recovery were observed in 4 patients (29%).60 
Three patients in MCS emerged and 1 patient with UWS regained response to command. It is 
however tricky to disentangle DBS effects from spontaneous recovery since these patients were 
enrolled between 2 and 11 months post-injury. Beside these two open-label studies, the only 
other study to employ a standardized and validated outcome measure (i.e., the CRS-R) to 
evaluate the efficacy of DBS in DOC is the seminal paper published in 2007,61 in which a TBI 
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patient in MCS for 6 years was treated with DBS of thalamic intralaminar nuclei in a double-
blind alternating crossover study (figure 2G).61 Clinically, after a few months of treatment, the 
patient recovered consistent command followings, oral feeding, and functional communication 
during the ‘on’ periods. When DBS was turned ‘off’, even if the clinical state of the patient 
decreased, it remained above baseline level suggesting some carryover effects.  
To date, no sham-controlled trial has been published on DBS in DOC. A treatment protocol still 
needs to be established along testing the generalizable effects of DBS against a common set of 
criteria. In addition, many clinical and ethical issues should still be addressed, as previously 
reported.62  
Finally, invasive VNS has been employed in one uncontrolled case-study of a patient who was in 
UWS for 15 years.63 The patient improved from UWS to MCS, and presented enhanced brain 
connectivity patterns (i.e., activity increase in occipito-parieto-frontal and basal ganglia regions; 
figure 2H). This case report needs to be taken cautiously as for all previous uncontrolled studies, 
but it illustrates the possibility of using this approach in patients with DOC. 
Sensory stimulation programs 
Stimulation programs include, among others, motor-based therapy, auditory-based training, 
music therapy and multi-sensory training program.  
In a single-blind RCT, the effects of conventional tilt table and its combination with a stepping 
device were assessed in 50 DOC patients (1-6 months post-injury).64 Behavioral improvements 
were noticed in both groups at the end of the 3-week intervention period, as well as at 3-week 
follow-up. No information was however provided regarding the type of behavioral recovery, and 
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since the study did not include a group with no therapy, the improvement could also be related to 
spontaneous recovery.  
The familiar auditory stimulation training (FAST65) was used in a double-blind RCT in 15 
patients with prolonged DOC (average of 70 days post-onset) after TBI.66 The FAST is 
composed of 5-min stories told by the patient’s relatives that involve autobiographical events, 
while the placebo protocol was “silence”. Both behavioral (using the Coma/Near Coma Scale – 
CNC20) and neuroimaging data showed better results for the FAST group than for the control 
group (i.e., more CNC gains and higher MRI activation in language regions and whole brain). 
Clinical improvements were however comprised within the boundaries of the CRS-R and the 
CNC scale, without changes of diagnosis and the reported baseline difference between groups 
may also be a bias in this study, as well as the small sample size.66  
The effects of music therapy were evaluated in a controlled case-series (two cycles of 15 
sessions of, separated by two weeks) in 10 patients with prolonged DOC (time range not 
specified) showing a slight behavioral enhancement (e.g., more eye contacts and smiles with less 
suffering expressions) and an improvement of hemodynamic parameters (i.e., systolic and 
diastolic pressure) in patients in MCS.67 Even if, to date, no double-blind RCT has been 
conducted to evaluate the clinical effects of music in patients with DOC, neuroimaging has 
shown higher activation of the auditory network and stronger neurophysiological responses (i.e., 
increase in P300 response) following music compared to other random sounds (figure 2I).68–71  
A recent uncontrolled ABAB protocol tested the effects of a multi-sensory stimulation program 
including auditory, visual, tactile, olfactory, and gustatory stimuli (20 minutes per session 
applied 3 days per week for 4 weeks).72 Higher CRS-R total scores were observed during the 
treatments periods (B) compared to baselines (A) in MCS but not in UWS patients groups. 
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Double-blind RCTs need to further evaluate the possible superiority of a multi-sensory approach 
as compared to only one type of stimulation.   
Hyperbaric oxygen therapy73 and acupuncture74 have also been tested in uncontrolled studies. 
However, most studies were not available in English and did not use validated scales.  
Until now, only one double-blind RCT has been conducted on sensory stimulations, showing that 
auditory stimulations (i.e., FAST protocol) could speed up recovery in patients with prolonged 
DOC as shown in a small sample double-blind class III RCT.  
 
Conclusion and future directions 
Management of patients with DOC is challenging because  of the absence of communication, the 
scarcity of interaction with their environment and their severe motor disability. Therefore, 
adapted therapeutic approaches that do not require patients’ active participation need to be 
developed. Present findings suggest that some patients may benefit from rehabilitative 
interventions,32,64,66 even years after the brain injury,29,33,35 which highlights the importance of 
management of patients with prolonged DOC. To date, as highlighted in the American practice 
guidelines for DOC patients,10 most studies are open-label studies and case-reports, in which 
results need to be taken with caution, and cannot yet be translated into clinical practice. 
However, several RCTs are being published in the last 5 years (table 1) but more robust designs 
and larger samples are still needed. 
Regarding pharmacological treatment, only a few RCTs have been conducted, among them, 
amantadine,11 is the only drug tested showing class II evidence for patients with TBI during 
rehabilitation and the only intervention recommended by the American practice guidelines for 
DOC.10 For neuromodulation, on the other hand, many studies and RCTs have been conducted in 
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this patient cohort, showing the growing interest in this field, that may be partially explained by 
the low cost and absence of severe side-effects reported. TDCS applied over DLPFC has been 
shown to induce some clinical improvement in 5 RCTs, 4 class III31,33–35 and 1 class II,29 in 
patients in MCS from TBI and non-TBI etiologies. Even if the sample sizes were relatively small 
(13 to 55 patients enrolled per study) and the field of non-invasive brain stimulation for patients 
with DOC is still at its infancy, tDCS seems a promising treatment approach for patients in MCS. 
For patients in UWS, no treatment effects were found at the group level using this 
intervention.29,32,33 rTMS has also been investigated in RCT in patients with DOC. However, at 
the group level, no behavioral enhancements were noticed in any of the RCTs when applied over 
M1.45,46,48 Future RCTs should target the DLPFC, similarly to tDCS, as two uncontrolled 
observational rTMS studies show some positive effects.50,51 Demographic and clinical 
characteristics of responders should also be investigated in larger RCTs or meta-analyses. Others 
brain areas could also be targeted according to patients’ brain lesions and neural residual 
function since patients’ clinical responsiveness seems to depend on this.37  
To move forward the field of therapeutic options for patients with DOC, large sample multi-
center RCT, stratified for the level of consciousness, etiology and duration of the disease, should 
be performed to confirm and validate the efficacy of a therapeutic intervention and to better 
target the clinical profile of patients who could benefit from this intervention. All future RCT 
also need to report how many patients were screened, enrolled or were lost at follow-up, 
especially when the sample size is small, which was not systematically done in the reported 
RCTs (table 1). Side-effects should also always be collected and reported.  
To advance the treatment of patients with prolonged DOC, combining therapeutic interventions 
with neuroimaging or neurophysiological assessments would also help to improve our 
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understanding of the neural correlates of a clinical response and therefore, of the possible 
neuroplastic mechanisms after an acquired brain injury. In addition, there is a crucial need to 
develop biomarkers of responsiveness to provide a personalized intervention based on the 
patients’ clinical characteristics and their brain lesions.     
In conclusion, several RCTs have been conducted but only two show class II evidence (on 
amantadine and tDCS) and large double-blind RCTs are still needed. Given the numerous 
challenges that represent this population (e.g., high rate of drop-out due to medical 
complications, ethical issues) such RCTs are nonetheless difficult to conduct. Based on the 
promising effects of some treatments in patients with prolonged DOC, especially in TBI (for 
amantadine11) and in MCS (for tDCS29), and given that some patients may still improve even 
years after the brain injury, we are convinced that the field of therapeutic interventions will make 
important scientific progress in the next years.   
Search strategy and selection criteria  
We searched on PubMed for articles published in English between January 1st 2013 and October 
31st 2018 using the following search terms: disorders of consciousness, vegetative state, 
unresponsive wakefulness syndrome or minimally conscious state, and therapy, treatment, 
therapeutics, revalidation or drugs. Out of 558 papers, 45 matched our inclusion criteria: clinical 
trial, open label study, observational study, and case report using validated behavioral tools on 
therapeutic intervention for patients with prolonged (> 28 days post-injury) disorders of 
consciousness aiming at improving consciousness and functional recovery. Sixteen of them were 
randomized controlled clinical trials. We did not include articles on rehabilitation methods not 
aiming at improving consciousness (e.g., speech therapy, spasticity management). We also 
excluded papers that did not use a validated scale. Additional references were collected and 
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reviewed from the included articles’ bibliography. Out of the 45 articles that matched our 
inclusion criteria, articles were selected based on their originality and relevance to this topic. 
Note that if no RCT were found for a therapeutic option but open-label studies or case-reports 
were available, we included them in the present review.  
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Glossary panel I – clinical entities (see figure 1) 
Coma 
Coma is the result of a severe brain injury, in which patients are unarousable (i.e., eyes closure 
even when stimulated) and unaware of themselves and their environment.75 This state is 
temporary and after several days or weeks, patients may either evolve to brain death (i.e., 
irreversible coma with absence of brainstem reflexes and apnea) or show some or full recovery. 
Unresponsive wakefulness syndrome  
When patients start opening their eyes but present only reflex movements, they are diagnosed 
with an unresponsive wakefulness syndrome (UWS) (previously termed ‘vegetative state’).76 
Patients in UWS exhibit no signs of awareness, but they can present a variety of reflexive 
movements, such as grinding teeth, yawning, or groaning.76 This condition may be transitory, 
prolonged or permanent.  
Minimally conscious state  
Once patients recover fluctuating but reproducible signs of consciousness, they enter into the 
minimally conscious state (MCS). This entity is divided into MCS- and MCS+ based on 
language processing.77,78 MCS- describes patients showing visual pursuit and fixation, 
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localization to noxious stimulation and/or automatic motor reactions (e.g., grasping bed sheets). 
Patients in MCS+ follow simple commands, can make understandable verbalizations or 
communicate intentionally but not functionally. As in UWS, MCS can be temporary or 
permanent. 
The diagnostic label of MCS* has been suggested for UWS patients who show no evidence of 
awareness at the bedside while neuroimaging data show atypical brain patterns using active 
paradigm (e.g., brain activity in motor area during a motor imagery task) and/or metabolic 
resting state (e.g., preservation of the fronto-parietal network).8,79,80 This entity allows a more 
clinically accurate diagnosis when the bedside examination shows no evidence of consciousness. 
Emergence from MCS  
When patients are able to functionally communicate and/or use adequately 2 different objects, 
they have emerged from the MCS. Most of these patients have still severe cognitive and motor  
impairements.77,78 Patients who are disoriented remain in a confusional state. 
Locked-in syndrome  
The locked-in syndrome (LIS) is defined by quadriplegia and anarthria due to a lesion in the 
corticospinal and corticobulbar pathways in the brainstem.81 These patients cannot move (some 
recover some distal movements – incomplete LIS) but their sensations remain intact and they are 
fully conscious. The most common way for these patients to communicate is via vertical eye 
movements and blinks.82 In the case of complete LIS (cLIS), a paralysis of the eyes prevent any 
communication and brain computer interfaces are needed.83 Finally, the term “functional LIS” 
(as well as “covert cognition”) has been proposed to indicate a dissociation between bedside 
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behaviour and the results of neuroimaging assessments84 (like MCS*8 and cognitive motor 
dissociation - CMD9)  
Cognitive motor dissociation  
The syndrome of cognitive motor dissociation (CMD) has been proposed to specifically refer to 
patients in coma, UWS or MCS- who show consistent brain activation during mental imagery 
tasks using functional magnetic resonance imaging (fMRI) or electroencephalography (EEG), 
and hence show command following using neuroimaging technologies.9 CMD indicates a wide 
range of uncertainty regarding the underlying cognitive capacity present in patients with no or 
little behavioural responses.  
Glossary panel II – neuromodulation techniques 
Transcranial Direct Current Stimulation (tDCS) 
This neuromodulation technique modulates cortical excitability through the application of a 
weak (usually ≤ 2mA) direct current through the brain between 2 electrodes, from the anode to 
the cathode. Physiologically, the establishment of the long-lasting after-effects depends on 
membrane potential changes as well as modulations of N-methyl-D-aspartate (NMDA) receptor 
efficacy, which can induce long-term potentiation and long-term depression like effects.85–87 
However, more mechanistic and in vivo studies need to be performed to better understand how 
tDCS can influence cortical activity and act on neuroplasticity. 
Transcranial Magnetic Stimulation (TMS)  
TMS uses an electromagnetic pulse to induce focalized neural depolarization and firing. 
Repeated TMS (rTMS), as compared to single pulses TMS, can influence brain plasticity and 
cortical organization via alterations of neuronal excitability. It has been used to induce a 
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sustained inhibition (~1Hz frequency) or activation (5-20 Hz frequency) of the neuronal 
population.  
Low intensity focused ultrasound pulse (LIFUP)  
This technique employs low-energy sound waves to excite or inhibit brain activity. Compared to 
tDCS and rTMS, it is, theoretically, capable of directly targeting and stimulating subcortical and 
deep brain structure such as the thalamus. 
Vagal nerve stimulation (VNS)  
VNS can be invasive and surgically placed or non-invasive via a transcutanous auricular 
stimulation (taVNS). taVNS consists of the injection of a thermal current to the external ear 
canal, which modifies the density of the endolymph in the internal ear and, as a consequence, 
alter the firing rate of the vestibular nerve. This technique is thought to induce compensatory 
responses, via basal forebrain/brainstem projections through central thalamus and hypothalamus, 
in distal fronto-parietal and striatal networks.88 Invasive VNS involves the surgical implantation 
of a vagus nerve stimulator, using a current of 1-2 mA. Mechanisms of stimulation are similar to 
taVNS.  
Deep brain stimulation 
This neurosurgical procedure involves the implantation of brain electrode that delivers a current 
to a targeted brain area. The underlying mechanisms of DBS are not yet fully understood.89 In 
patients with severe brain injuries, the main target is the central thalamus to induce excitation of 
the projecting thalamo-cortical afference. The electrodes are usually implanted in the 
intralaminar nuclei because this region seems to be particularly associated with DOC patients’ 
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level of recovery,90 and because of the pathophysiological mechanisms linked to the brain injury 
and cellular loss in the central thalamus.91  
Figures legends 
Figure 1: Motor and cognitive evolution following a severe brain injury. The different 
diagnoses after a severe brain injury can be best captured on a 2-dimensional axis by comparing 
the degree of impaired cognitive function against the degree of motor function. Red circles 
represent patients who are unconscious with limited reflexive movements (coma and 
unresponsive wakefulness syndrome – UWS). Blue circles represent patients in minimally 
conscious state (MCS+ and MCS- depending on language preservation). When functional 
communication is detected (yellow circles) patients emerge from MCS (EMCS) and can evolve 
to a confusional state (CS), severe or moderated disability, before a full recovery (green circle). 
Dissociations between motor and cognitive functions exist in the locked-in syndrome (LIS, green 
circle), in the cognitive motor dissociation (CMD), and in the MCS* (purple circles). In rare 
cases, the diagnosis of complete LIS (cLIS) can be done through neuroimaging exams. See 
glossary panel for more information. Black-white gradient represents the evolution from absence 
(black) to the recovery of a behavior (white) (e.g., no command following to consistent 
command following). 
Figure 2: Neuroimaging results and neurophysiology associated with potential 
pharmacological and non-pharmacological interventions to improve consciousness in 
patients with disorders of consciousness (DOC). (A) Amantadine has been shown to increase 
brain metabolism in the fronto-parietal network in one patient in minimally conscious state 
(MCS)12 while (B) zolpidem induced an increase in brain metabolism in the prefrontal and 
mesiofrontal cortex in 3 MCS responders.26 (C) Transcranial direct current stimulation (tDCS) 
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responders (n=8) presented more preservation of brain metabolism in the prefrontal cortex 
(stimulated area) as compared to non-responders (n=13);37 (D) repetitive transcranial magnetic 
stimulation (rTMS) of 20 Hz on the primary motor cortex induced EEG increases in beta 
(shown), alpha, and delta, bands power in one MCS responder;49 (E) Low intensity focused 
ultrasound pulsation (LIFUP56) is shown in a patient with unresponsive wakefulness syndrome 
(UWS) who became MCS after LIFUP with the transducer with the thalamic target (red circle); 
(F) Transcutaneous auricular vagal nerve stimulation (taVNS) induced increases in functional 
connectivity between posterior cingulate/precuneus and hypothalamus, thalamus, prefrontal 
cortex, temporal gyrus (red) and decrease between the posterior cingulate/precuneus and 
cerebellum (blue) in one UWS patient who became MCS after taVNS.53 (G) Deep brain 
stimulation (DBS) electrode placement, as seen with MRI, in one MCS patient who recovered 
subsequently;61,92 (H) Brain connectivity patterns after invasive vagal nerve stimulation (VNS) 
as measured with high-density electroencephalography (EEG) in one UWS patient who became 
MCS.63 (I) Music stimulation induced an increase in functional connectivity in the auditory 
network (and in the default mode network – not shown) in 5 DOC patients.68 
Figure 3: The mesocircuit fronto-parietal model. This model provides a framework that 
explains the potential mechanisms of action of various therapeutic interventions and sheds light 
on the neural mechanisms of impaired consciousness. This model supports the idea that, in 
normal cognitive processing, the central thalamus is regulated by both the dominant 
corticothalamic feedback provided by (pre)frontal regions and via an inhibitory modulation by 
the internal globus pallidus which itself is regulated by cortico-striatal and thalamostriatal inputs. 
Activation of the central thalamus broadly drives activity of associative fronto-parietal cortical 
areas.93 On the other hand, in case of brain injury, a reduction of thalamocortical and 
 27 
thalamostriatal outflow following deafferentation and loss of neurons from the central thalamus 
withdraws important afferent drive to the medium spiny neurons of the striatum (green lines). 
This may then fail to reach firing threshold because of their requirement for high levels of 
synaptic background activity. Loss of active inhibition from the striatum (dashed red line) allows 
neurons of the globus pallidus interna (GPI) to tonically fire and provide active inhibition (red 
line) to their synaptic targets, including relay neurons of the already strongly disfacilitated 
central thalamus. This mesocircuit model may explain the potential mechanisms of several 
treatments that have shown promising results in the recovery of consciousness in severely brain-
injured patients. A partial preservation of the stimulated prefrontal cortex seems to be necessary 
to induce a clinical tDCS response,37 while rTMS seems to induce a global increase in cortical 
oscillations when applied over the primary motor cortex.49 The clinical improvement of a patient 
who responded to amantadine correlated with an increased fronto-parietal brain metabolism.12 
Zolpidem may reduce the inhibition of the thalamus by activating the striatum.27 DBS directly 
acts over the central thalamus aiming to stimulate the thalamo-cortical connectivity,61 while 
LIFUP stimulates the thalamus in a non-invasive way.56 Finally, invasive and non-invasive VNS 
directly stimulate the vagal nerve.53,63 Blue circles represent subcortical regions; while purple 
rectangles represent cortical areas. Green lines stand for weak excitation, red lines for excess of 
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